FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2057808769> ?p ?o ?g. }

• W2057808769 endingPage "655" @default.
• W2057808769 startingPage "651" @default.
• W2057808769 abstract "Purpose of review The treatment of chronic kidney disease-mineral bone disorder (CKD-MBD) has traditionally focused on improvement in biochemical parameters of the disease. However, studies evaluating hard clinical end points or surrogate end points are limited. Recent findings Two randomized controlled trials have recently been published. In the EVOLVE study (Evaluation of Cinacalcet Hydrochloride Therapy to Lower Cardiovascular Events), cinacalcet was compared with placebo in 3883 haemodialysis patients with secondary hyperparathyroidism. The primary end point (death, myocardial infarction, unstable angina, heart failure or peripheral vascular disease) in an unadjusted intention-to-treat analysis was not significant [hazard ratio 0.93; 95% confidence interval (CI) 0.85–1.02, P = 0.11]. However, the pre-specified secondary end points of an adjusted intention-to-treat analysis (hazard ratio 0.88; 95% CI 0.79–0.97, P = 0.008) were significant. In the PRIMO (Paricalcitol Capsule Benefits in Renal Failure Induced Cardiac Morbidity) trial, 227 patients with CKD stage 3–4 and left ventricular hypertrophy by echocardiography were randomized to paricalcitol or placebo. The primary end point of change in left ventricular mass index by MRI after 12 months was not different between the two groups, but the prespecified end point of cardiovascular-related hospitalizations was reduced in the paricalcitol-treated group (P = 0.04). Summary The results of these two randomized controlled trials have negative primary end points but significant secondary end points and thus require physicians to individualize therapies for the treatment of secondary hyperparathyroidism." @default.
• W2057808769 created "2016-06-24" @default.
• W2057808769 creator A5041339585 @default.
• W2057808769 creator A5074659892 @default.
• W2057808769 date "2013-11-01" @default.
• W2057808769 modified "2023-09-26" @default.
• W2057808769 title "What have we learned about chronic kidney disease-mineral bone disorder from the EVOLVE and PRIMO trials?" @default.
• W2057808769 cites W1976544899 @default.
• W2057808769 cites W1984740481 @default.
• W2057808769 cites W1988032328 @default.
• W2057808769 cites W2015668150 @default.
• W2057808769 cites W2036526711 @default.
• W2057808769 cites W2047856826 @default.
• W2057808769 cites W2060331245 @default.
• W2057808769 cites W2067571594 @default.
• W2057808769 cites W2069942555 @default.
• W2057808769 cites W2070309439 @default.
• W2057808769 cites W2078808411 @default.
• W2057808769 cites W2097886046 @default.
• W2057808769 cites W2103326270 @default.
• W2057808769 cites W2109649607 @default.
• W2057808769 cites W2110152372 @default.
• W2057808769 cites W2110601215 @default.
• W2057808769 cites W2116618632 @default.
• W2057808769 cites W2121781079 @default.
• W2057808769 cites W2123298052 @default.
• W2057808769 cites W2129321769 @default.
• W2057808769 cites W2134820952 @default.
• W2057808769 cites W2136666186 @default.
• W2057808769 cites W2138247546 @default.
• W2057808769 cites W2152330606 @default.
• W2057808769 cites W2159126630 @default.
• W2057808769 cites W2163383835 @default.
• W2057808769 cites W2172159264 @default.
• W2057808769 doi "https://doi.org/10.1097/mnh.0b013e328365b3a3" @default.
• W2057808769 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3983668" @default.
• W2057808769 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24100218" @default.
• W2057808769 hasPublicationYear "2013" @default.
• W2057808769 type Work @default.
• W2057808769 sameAs 2057808769 @default.
• W2057808769 citedByCount "13" @default.
• W2057808769 countsByYear W20578087692014 @default.
• W2057808769 countsByYear W20578087692015 @default.
• W2057808769 countsByYear W20578087692016 @default.
• W2057808769 countsByYear W20578087692017 @default.
• W2057808769 countsByYear W20578087692018 @default.
• W2057808769 countsByYear W20578087692019 @default.
• W2057808769 countsByYear W20578087692021 @default.
• W2057808769 crossrefType "journal-article" @default.
• W2057808769 hasAuthorship W2057808769A5041339585 @default.
• W2057808769 hasAuthorship W2057808769A5074659892 @default.
• W2057808769 hasBestOaLocation W20578087692 @default.
• W2057808769 hasConcept C126322002 @default.
• W2057808769 hasConcept C126894567 @default.
• W2057808769 hasConcept C141071460 @default.
• W2057808769 hasConcept C142724271 @default.
• W2057808769 hasConcept C164705383 @default.
• W2057808769 hasConcept C168563851 @default.
• W2057808769 hasConcept C203092338 @default.
• W2057808769 hasConcept C204787440 @default.
• W2057808769 hasConcept C207103383 @default.
• W2057808769 hasConcept C27081682 @default.
• W2057808769 hasConcept C2776036575 @default.
• W2057808769 hasConcept C2777425297 @default.
• W2057808769 hasConcept C2778653478 @default.
• W2057808769 hasConcept C2778838027 @default.
• W2057808769 hasConcept C2779524405 @default.
• W2057808769 hasConcept C2780534505 @default.
• W2057808769 hasConcept C2781208988 @default.
• W2057808769 hasConcept C44249647 @default.
• W2057808769 hasConcept C500558357 @default.
• W2057808769 hasConcept C519063684 @default.
• W2057808769 hasConcept C71924100 @default.
• W2057808769 hasConceptScore W2057808769C126322002 @default.
• W2057808769 hasConceptScore W2057808769C126894567 @default.
• W2057808769 hasConceptScore W2057808769C141071460 @default.
• W2057808769 hasConceptScore W2057808769C142724271 @default.
• W2057808769 hasConceptScore W2057808769C164705383 @default.
• W2057808769 hasConceptScore W2057808769C168563851 @default.
• W2057808769 hasConceptScore W2057808769C203092338 @default.
• W2057808769 hasConceptScore W2057808769C204787440 @default.
• W2057808769 hasConceptScore W2057808769C207103383 @default.
• W2057808769 hasConceptScore W2057808769C27081682 @default.
• W2057808769 hasConceptScore W2057808769C2776036575 @default.
• W2057808769 hasConceptScore W2057808769C2777425297 @default.
• W2057808769 hasConceptScore W2057808769C2778653478 @default.
• W2057808769 hasConceptScore W2057808769C2778838027 @default.
• W2057808769 hasConceptScore W2057808769C2779524405 @default.
• W2057808769 hasConceptScore W2057808769C2780534505 @default.
• W2057808769 hasConceptScore W2057808769C2781208988 @default.
• W2057808769 hasConceptScore W2057808769C44249647 @default.
• W2057808769 hasConceptScore W2057808769C500558357 @default.
• W2057808769 hasConceptScore W2057808769C519063684 @default.
• W2057808769 hasConceptScore W2057808769C71924100 @default.
• W2057808769 hasIssue "6" @default.
• W2057808769 hasLocation W20578087691 @default.
• W2057808769 hasLocation W20578087692 @default.
• W2057808769 hasLocation W20578087693 @default.

• next